Galectin-9 promotes TGF-β1-dependent induction of regulatory T cells via the TGF-β/Smad signaling pathway

Molecular Medicine Reports

Volumn 7, Issue 1, 2013, Pages 205-210

  Lv, Kun ^a,b   Zhang, Yingying ^b   Zhang, Mengying ^a   Zhong, Min ^a   Suo, Qifeng ^a  

^a Central Laboratory   (China)

^b WANNAN MEDICAL COLLEGE   (China)

Author keywords

Conversion; Galectin 9; Phosphorylation; Regulatory T cells

Indexed keywords

CD4 ANTIGEN; ECALECTIN; INTERLEUKIN 2 RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL EXPANSION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

ANIMALS; DRUG SYNERGISM; FORKHEAD TRANSCRIPTION FACTORS; GALECTINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MULTIPROTEIN COMPLEXES; PHOSPHORYLATION; PROTEIN BINDING; SIGNAL TRANSDUCTION; SMAD PROTEINS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84873873456     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1125     Document Type: Article

References (38)

1. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6: 345-352, 2005.
2. + regulatory T cells. Nat Immunol 4: 330-336, 2003.
3. Wan YY and Flavell RA: Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445: 766-770, 2007.
4. + regulatory T cells. Front Biosci 11: 1014-1023, 2006.
5. + T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172: 5149-5153, 2004.
6. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 198: 1875-1886, 2003.
7. + T regulatory cells: role of tumor-derived TGF-β. J Immunol 178: 2883-2892, 2007.
8. + regulatory T cells invivo requires B7 costimulation, but not the thymus. J Exp Med 201: 127-137, 2005.
9. Knoechel B, Lohr J, Kahn E, etal: Sequential development of interleukin 2-dependent effector and regulatory T cells in response to endogenous systemic antigen. J Exp Med 202: 1375-1386, 2005.
10. 3+ and Foxp3-precursor cells in the absence of interleukin 10. Nat Immunol 8: 931-941, 2007.
11. 3+ regulatory T cells and for expansion of these cells. J Immunol 178: 2018-2027, 2007.
12. Polansky JK, Kretschmer K, Freyer J, etal: DNA methylation controls Foxp3 gene expression. Eur J Immunol 38: 1654-1663, 2008.
13. Shull MM, Ormsby I, Kier AB, etal: Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 359: 693-699, 1992.
14. Kulkarni AB, Huh CG, Becker D, etal: Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90: 770-774, 1993.
15. Lucas PJ, Kim SJ, Melby SJ, etal: Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor β II receptor. J Exp Med 191: 1187-1196, 2000.
16. Gorelik L and Flavell RA: Abrogation of TGF β signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171-181, 2000.
17. Li MO, Sanjabi S and Flavell RA: Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and-independent mechanisms. Immunity 25: 455-471, 2006.
18. + T cells. J Immunol 173: 6526-6531, 2004.
19. + regulatory T cells. J Exp Med 201: 1061-1067, 2005.
20. Saita N, Goto E, Yamamoto T, etal: Association of galectin-9 with eosinophil apoptosis. Int Arch Allergy Immunol 128: 42-50, 2002.
21. Kageshita T, Kashio Y and Yamauchi A: Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer 99: 809-816, 2002.
22. Wada J, Ota K, Kumar A, etal: Developmental regulation, expression, and apoptotic potential of galectin-9, a β-galactoside binding lectin. J Clin Invest 99: 2452-2461, 1997.
23. Matsumoto R, Matsumoto H, Seki M, etal: A variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 273: 16976-16984, 1998.
24. Kashio Y, Nakamura K and Abedin MJ: Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol 170: 3631-3636, 2003.
25. Zhu C, Anderson AC, Schubart A, etal: The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6: 1245-1252, 2005.
26. Tsuboi Y, Abe H, Nakagawa R, etal: Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes. Clin Immunol 124: 221-233, 2007.
27. Fukushima, Tamaki S and Fukuda K: Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice. Int Arch Allergy Immunol 146: 36-43, 2008.
28. Seki M, Oomizu S, Sakata K, etal: Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 127: 78-88, 2008.
29. Sharvan S, Amol S, Hirashima M, etal: Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J Immunol 182: 3191-3201, 2009.
30. Lv K, Xu W, Wang CN, etal: Galectin-9 administration ameliorates CVB3 induced myocarditis by promoting the proliferation of regulatory T cells and alternatively activated Th2 cells. Clin Immunol 140: 92-101, 2011.
31. Derynck R and Zhang YE: Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584, 2003.
32. 3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J Exp Med 204: 1757-1764, 2007.
33. +CD25-lymphocytes is thymus and proliferation independent. Cancer Res 66: 4488-4495, 2006.
34. 3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut 55: 671-680, 2006.
35. Massague J: How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1: 169-178, 2000.
36. Massague J: TGF-beta signal transduction. Annu Rev Biochem 67: 753-791, 1998.
37. Massague J and Chen YG: Controlling TGF-beta signaling. Genes Dev 14: 627-644, 1998.
38. Massague J and Wotton D: Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19: 1745-1754, 2000.